Table 2.
Associations between response mode and reporting a satisfied experience of cancer care (scores 9 or 10 to question 59): frequency and percentage and related crude and adjusted odds ratios of reporting a satisfied experience (N=60,921).
| Variable | Frequency and percentage of reporting a satisfied experience | Univariable logistic regression models | Multivariable logistic regression model | ||||
|
|
n (%) | Total, N | ORa (95% CI) | P valueb | aORc (95% CI) | P valueb | |
| Response mode |
|
<.001 | <.001 | ||||
|
|
Postal | 35,809 (63.58) | 56,318 | 1 |
|
1 |
|
|
|
Online | 3082 (66.96) | 4603 | 1.16 (1.09-1.24) |
|
1.24 (1.16-1.32) |
|
| Sex |
|
.01 | <.001 | ||||
|
|
Male | 18,006 (64.36) | 27,976 | 1 |
|
1 |
|
|
|
Female | 20,885 (63.39) | 32,945 | 0.96 (0.93-0.99) |
|
0.89 (0.85-0.92) |
|
| Age group (years) |
|
<.001 | <.001 | ||||
|
|
<55 | 5551 (59.73) | 9294 | 0.77 (0.73-0.81) |
|
0.75 (0.71-0.79) |
|
|
|
55-64 | 7828 (62.18) | 12,590 | 0.85 (0.81-0.89) |
|
0.84 (0.81-0.88) |
|
|
|
65-74 | 14,286 (65.88) | 21,686 | 1 |
|
1 |
|
|
|
≥75 | 11,226 (64.70) | 17,351 | 0.95 (0.91-0.99) |
|
0.97 (0.93-1.01) |
|
| IMD score |
|
<.001 | <.001 | ||||
|
|
Quintile 1 (least deprived) | 9575 (64.82) | 14,772 | 1 |
|
1 |
|
|
|
Quintile 2 | 9326 (65.10) | 14,326 | 1.01 (0.97-1.06) |
|
1.02 (0.97-1.07) |
|
|
|
Quintile 3 | 8613 (64.41) | 13,373 | 0.98 (0.94-1.03) |
|
1.01 (0.96-1.06) |
|
|
|
Quintile 4 | 6513 (61.65) | 10,565 | 0.87 (0.83-0.92) |
|
0.92 (0.87-0.97) |
|
|
|
Quintile 5 (most deprived) | 4864 (61.69) | 7885 | 0.87 (0.83-0.93) |
|
0.95 (0.89-1.00) |
|
| Ethnic group |
|
<.001 | <.001 | ||||
|
|
White | 36,343 (64.80) | 56,088 | 1 |
|
1 |
|
|
|
Nonwhite | 2548 (52.72) | 4833 | 0.61 (0.57-0.64) |
|
0.63 (0.59-0.67) |
|
| Cancer sited |
|
<.001 | <.001 | ||||
|
|
Non-Hodgkin lymphoma | 3025 (70.25) | 4306 | 1.36 (1.23-1.50) |
|
1.38 (1.25-1.53) |
|
|
|
Leukemia | 1604 (69.86) | 2296 | 1.34 (1.19-1.50) |
|
1.36 (1.21-1.53) |
|
|
|
Breast | 8257 (65.95) | 12,521 | 1.12 (1.03-1.21) |
|
1.30 (1.19-1.42) |
|
|
|
Endometrial | 880 (65.67) | 1340 | 1.10 (0.96-1.26) |
|
1.21 (1.06-1.39) |
|
|
|
Colon | 2800 (64.35) | 4351 | 1.04 (0.94-1.15) |
|
1.05 (0.95-1.16) |
|
|
|
Rectal | 1898 (63.44) | 2992 | 1 |
|
1 |
|
|
|
Multiple myeloma | 2788 (63.31) | 4404 | 0.99 (0.90-1.10) |
|
0.99 (0.90-1.09) |
|
|
|
Other | 9634 (61.39) | 15,692 | 0.92 (0.85-0.99) |
|
0.96 (0.89-1.05) |
|
|
|
Lung | 2002 (61.45) | 3258 | 0.92 (0.83-1.02) |
|
0.92 (0.83-1.02) |
|
|
|
Bladder | 2600 (61.19) | 4249 | 0.91 (0.83-1.00) |
|
0.86 (0.78-0.95) |
|
|
|
Prostate | 3403 (61.74) | 5512 | 0.93 (0.85-1.02) |
|
0.86 (0.78-0.94) |
|
|
|
Total | 38,891 (63.84) | 60,921 |
|
|
|
|
aUnadjusted odds ratios (ORs) of reporting a satisfied experience from a series of univariable logistic regression models, conditional on each of the response mode, patient characteristic and cancer site variables considered.
bP values from joint Wald tests.
cAdjusted odds ratios (aORs) of reporting a satisfied experience from a multivariable logistic regression model, conditional on response mode and all patient characteristic and cancer site variables considered.
dResponders with renal and thyroid cancers (grouped into the “other” category) and melanoma skin cancer excluded due to their ethnic group being suppressed or missing.